Metraipolis › archive › dc_ceb8a83acec2

Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated Melanoma — Europe PMC PMID:40940903

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940903
DOI
10.3390/cancers17172806
License (as archived)
solo-consultazione
Archived
2026-11-10T07:55:47.178Z
SHA-256 of the archived text
a2c0cec3c9a1e551a1e3c56fe20c87a149671b9ef068722bb1dc8a314471f2de
Stable URL of this page
https://metraipolis.com/documento/dc_ceb8a83acec2

How to cite

Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated Melanoma — Europe PMC PMID:40940903 — Europe PMC (en), https://europepmc.org/article/MED/40940903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ceb8a83acec2 (Metraipolis archive dc_ceb8a83acec2, sha256 a2c0cec3c9a1e551a1e3c56fe20c87a149671b9ef068722bb1dc8a314471f2de)
BibTeX
@misc{dcceb8a83acec2,
  title = {Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated Melanoma — Europe PMC PMID:40940903},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940903},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ceb8a83acec2; sha256 a2c0cec3c9a1e551a1e3c56fe20c87a149671b9ef068722bb1dc8a314471f2de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940903. Agents can read the archived copy with the MCP tool read_document.